These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

112 related items for PubMed ID: 6169961

  • 1. Labetalol and the management of hypertension.
    Reid JL, Meredith PA, Elliott HL.
    J Cardiovasc Pharmacol; 1981; 3 Suppl 1():S60-8. PubMed ID: 6169961
    [No Abstract] [Full Text] [Related]

  • 2. Intravenous labetalol in the treatment of severe hypertension.
    Cumming AM, Brown JJ, Lever AF, Robertson JI.
    Br J Clin Pharmacol; 1982 Jun; 13(1 Suppl):93S-96S. PubMed ID: 7093105
    [Abstract] [Full Text] [Related]

  • 3. [Malignant pheochromocytoma: blood pressure controlled by labetalol].
    Sugano O, Hirano J, Hirano K, Kubota Y, Numasawa K, Kawamura S.
    Nihon Hinyokika Gakkai Zasshi; 1984 Mar; 75(3):523-7. PubMed ID: 6471663
    [No Abstract] [Full Text] [Related]

  • 4. Labetalol in the treatment of a patient with phaechromocytoma: a case report.
    Bailey RR.
    Br J Clin Pharmacol; 1979 Mar; 8(Suppl 2):141S-142S. PubMed ID: 526394
    [No Abstract] [Full Text] [Related]

  • 5. Labetalol: the nineteen-eighties.
    Robertson JI.
    Br J Clin Pharmacol; 1982 Jun; 13(1 Suppl):137S-141S. PubMed ID: 7093098
    [No Abstract] [Full Text] [Related]

  • 6. Treatment of phaeochromocytoma and of clonidine withdrawal hypertension with labetalol.
    Rosei EA, Brown JJ, Lever AF, Robertson AS, Robertson JI, Trust PM.
    Br J Clin Pharmacol; 1976 Aug; 3(4 Suppl 3):809-15. PubMed ID: 990158
    [Abstract] [Full Text] [Related]

  • 7. Use of labetalol during anesthesia for pheochromocytoma removal.
    Van Stratum M, Levarlet M, Lambilliotte JP, Lignian H, de Rood M.
    Acta Anaesthesiol Belg; 1983 Dec; 34(4):233-40. PubMed ID: 6673473
    [Abstract] [Full Text] [Related]

  • 8. Use of labetalol in hypertensive patients during discontinuation of clonidine therapy.
    Rosenthal T, Rabinowitz B, Boichis H, Elazar E, Brauner A, Neufeld HN.
    Eur J Clin Pharmacol; 1981 Dec; 20(4):237-40. PubMed ID: 6273179
    [Abstract] [Full Text] [Related]

  • 9. Labetalol (AH5158), a competitive alpha- and beta-receptor blocking drug, in the management of hypertension.
    Rosei EA, Brown JJ, Fraser R, Lever AF, Morton JJ, Robertson JI, Trust PM.
    Aust N Z J Med; 1976 Aug; 6(3 Suppl):83-8. PubMed ID: 14627
    [Abstract] [Full Text] [Related]

  • 10. Combined alpha- and beta-receptor inhibition in the treatment of hypertension.
    Prichard BN.
    Drugs; 1984 Aug; 28 Suppl 2():51-68. PubMed ID: 6151891
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Use of vecuronium and labetalol in patients with phaeochromocytoma.
    van Hasselt G, MacKenzie I, Edwards JC.
    Anaesthesia; 1984 Sep; 39(9):942-3. PubMed ID: 6152731
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Comparison of labetalol, clonidine and diazoxide intravenously administered in severe hypertension.
    Yeung CK, Thomas GW, Whitworth JA, Kincaid-Smith P.
    Med J Aust; 1979 Nov 03; 2(9):499-500. PubMed ID: 522807
    [Abstract] [Full Text] [Related]

  • 20. [Clinical effects of labetalol on pheochromocytoma].
    Yoshinaga K, Arakawa K, Ando H, Iai F, Ikeda M.
    Horumon To Rinsho; 1983 Feb 03; 31(2):183-92. PubMed ID: 6340865
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.